Financhill
Back

Matinas BioPharma Holdings Quote, Financials, Valuation and Earnings

Matinas BioPharma Holdings Price Quote

$0.71
-0.04 (-4.83%)
(Updated: November 13, 2024 at 5:55 PM ET)

Matinas BioPharma Holdings Key Stats

Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell

Day range:
$0.69 - $0.97
52-week range:
$0.50 - $21.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.78
P/B ratio:
0.2%

Volume:
442.2K
Avg. volume:
365.9K
1-year change:
-93%
Market cap:
$3.7M
Revenue:
$1.1M
EPS:
$-5.5

How Much Does Matinas BioPharma Holdings Make?

Data Unavailable

Is Matinas BioPharma Holdings Growing As A Company?

Data Unavailable

Matinas BioPharma Holdings Stock Price Performance

What Is Matinas BioPharma Holdings 52-Week High & Low?

Matinas BioPharma Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Matinas BioPharma Holdings?

Is Matinas BioPharma Holdings Cash Flow Positive?

  • What Is MTNB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.9M
  • What Is Matinas BioPharma Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.2M
  • What Is Matinas BioPharma Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $3.1M

Matinas BioPharma Holdings Return On Invested Capital

Data Unavailable

Matinas BioPharma Holdings Earnings Date & Stock Price

Matinas BioPharma Holdings Competitors

Matinas BioPharma Holdings Dividend Yield

Matinas BioPharma Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 98%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 3921.45%

Major Shareholders

  • How many MTNB shares are owned by institutional investors?
    37.8M MTNB shares are owned by institutional investors
  • How many MTNB shares are owned by insiders?
    11.3M MTNB shares are owned by insiders